X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (23) 23
index medicus (21) 21
mice (21) 21
humans (15) 15
respiratory system (14) 14
mice, inbred c57bl (11) 11
male (10) 10
air pollution (9) 9
lungs (9) 9
mortality (9) 9
article (8) 8
cell biology (8) 8
lung - pathology (8) 8
rats (8) 8
rodents (8) 8
apoptosis (7) 7
biochemistry & molecular biology (7) 7
lung - metabolism (7) 7
reactive oxygen species - metabolism (7) 7
alveoli (6) 6
exposure (6) 6
inflammation (6) 6
research article (6) 6
biology (5) 5
critical care medicine (5) 5
disease models, animal (5) 5
epithelial cells - metabolism (5) 5
gene expression (5) 5
lung (5) 5
macrophages (5) 5
medicine (5) 5
mice, knockout (5) 5
pulmonary alveoli - cytology (5) 5
pulmonary alveoli - metabolism (5) 5
pulmonary fibrosis (5) 5
air-pollution (4) 4
alveolar macrophages (4) 4
analysis (4) 4
bronchoalveolar lavage fluid - chemistry (4) 4
critical care (4) 4
epithelial cells - drug effects (4) 4
expression (4) 4
fluorescent protein indicators (4) 4
health aspects (4) 4
influenza (4) 4
lung diseases (4) 4
mitochondria (4) 4
particle size (4) 4
pulmonology (4) 4
science (4) 4
thrombosis (4) 4
abridged index medicus (3) 3
acute respiratory distress syndrome (3) 3
adenosine triphosphatase (3) 3
animal models (3) 3
articles (3) 3
asbestos (3) 3
cell death (3) 3
cell line (3) 3
cells, cultured (3) 3
cytokines (3) 3
emergency services (3) 3
epithelial cells - cytology (3) 3
epithelial cells - enzymology (3) 3
epithelium (3) 3
fibrosis (3) 3
hyperoxia (3) 3
immunology (3) 3
infections (3) 3
laminin (3) 3
long-term exposure (3) 3
lung - cytology (3) 3
lung - virology (3) 3
lung injury (3) 3
mitochondria - metabolism (3) 3
na,k-atpase (3) 3
orthomyxoviridae infections - virology (3) 3
particles (3) 3
particulate matter (3) 3
particulate matter - adverse effects (3) 3
patients (3) 3
pneumonia - metabolism (3) 3
proteins (3) 3
pulmonary alveoli - drug effects (3) 3
rats, sprague-dawley (3) 3
respiratory tract diseases (3) 3
respiratory-distress-syndrome (3) 3
sodium-potassium-exchanging atpase - metabolism (3) 3
viruses (3) 3
air pollutants - toxicity (2) 2
apoptosis - physiology (2) 2
b cells (2) 2
bax (2) 2
bcl-2-associated x protein - metabolism (2) 2
biocompatible materials - toxicity (2) 2
biopsy (2) 2
body weight (2) 2
bronchoalveolar lavage (2) 2
calcium channel (2) 2
calcium channels (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Experimental Medicine, ISSN 0022-1007, 08/2017, Volume 214, Issue 8, pp. 2387 - 2404
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 06/2019, Volume 199, Issue 12, pp. 1517 - 1536
Journal Article
Nano Letters, ISSN 1530-6984, 12/2011, Volume 11, Issue 12, pp. 5201 - 5207
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 04/2011, Volume 183, Issue 8, pp. 1043 - 1054
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 4, p. e18525
Background: Exposure of human populations to ambient particulate matter (PM) air pollution significantly contributes to the mortality attributable to ischemic... 
PLASMINOGEN-ACTIVATOR | MYOCARDIAL-INFARCTION | BIOLOGY | NECROSIS-FACTOR-ALPHA | DIESEL-EXHAUST INHALATION | AIR-POLLUTION PARTICLES | CORONARY-HEART-DISEASE | FACTOR PATHWAY INHIBITOR | TISSUE FACTOR | EXPOSURE | ADIPOSE-TISSUE | Tumor Necrosis Factor-alpha - metabolism | Lung - pathology | Humans | Particulate Matter - adverse effects | Pneumonia - pathology | Adipose Tissue, White - metabolism | Interleukin-6 | Particle Size | Animals | Plasminogen Activator Inhibitor 1 - metabolism | Inhalation Exposure | Cell Line, Tumor | Pneumonia - blood | Transcription, Genetic | Lung - metabolism | Mice | Blood Coagulation - physiology | Cities | Plasminogen Activator Inhibitor 1 - genetics | Fibrin - metabolism | Pneumonia - metabolism | Biometrics | Adipose tissue | Coagulation | Critical care | Oncology | Cardiovascular disease | mRNA | Activation | Macrophages | Human populations | Interleukin 6 | Ischemia | Etanercept | Atherosclerosis | Pollution abatement | Alveoli | Trachea | Particulate emissions | Outdoor air quality | Cytokines | Hematology | Mortality | Polyamide-imides | Particulates | Inflammation | Exposure | Tumor necrosis factor-α | Thrombosis | Thrombolysis | Medicine | Polymerase chain reaction | Lungs | Hyperoxia | Particulate matter | Air pollution | Emergency services | Cardiovascular diseases | Apoptosis
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 01/2009, Volume 284, Issue 4, pp. 2176 - 2186
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e35788
Rationale: HMG-CoA reductase inhibitors such as rosuvastatin may have immunomodulatory and anti-inflammatory effects that may reduce the severity of influenza... 
UNITED-STATES | MORTALITY | VIRUS | STATIN THERAPY | PANDEMIC INFLUENZA | BIOLOGY | POPULATION-BASED COHORT | CARDIOVASCULAR-DISEASE | INHIBITORS | PNEUMONIA | SEVERE SEPSIS | Influenza A Virus, H3N2 Subtype - drug effects | Influenza A Virus, H1N1 Subtype - physiology | Male | Fluorobenzenes - pharmacology | Lung - virology | Lung - metabolism | Orthomyxoviridae Infections - drug therapy | Disease Models, Animal | Cell Line | Virus Replication - drug effects | Antiviral Agents - pharmacology | Lung - pathology | Cytokines - metabolism | Macrophages - pathology | Mice, Inbred C57BL | Orthomyxoviridae Infections - pathology | Rosuvastatin Calcium | Pyrimidines - pharmacology | Influenza A Virus, H1N1 Subtype - drug effects | Sulfonamides - pharmacology | Pneumonia - virology | Macrophages - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Pneumonia - drug therapy | Lung - drug effects | Influenza A Virus, H3N2 Subtype - physiology | Mice | Bronchoalveolar Lavage Fluid - chemistry | Pneumonia - metabolism | Orthomyxoviridae Infections - virology | Infection | Lung diseases | Swine influenza | Rosuvastatin | B cells | Health aspects | Antilipemic agents | Animal models | Pneumonia | Pandemics | Homeostasis | Critical care | Viruses | Cardiovascular disease | Infections | Bronchoalveolar lavage | Human immunodeficiency virus--HIV | Tumor necrosis factor-TNF | Alveoli | Statins | Injuries | Immunization | Cytokines | HMG-CoA reductase inhibitors | Immunomodulation | Mortality | Rheumatology | Bronchus | Inflammation | Cholesterol | Medicine | Hypotheses | Respiratory syncytial virus | Inhibitors | Lungs | Swine flu | Influenza | Ligands | Replication | Hydroxymethylglutaryl-CoA reductase | Emergency services | Sepsis | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2014, Volume 9, Issue 9, p. e108138
Journal Article